Savino Sciascia (@SavinoSciascia) / Twitter
Update on the Treatment of Systemic Lupus Erythematosus - Ana M Arango, John D Reveille, 2006
Inhibition of the mtorc pathway in the antiphospholipid
PDF) Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository
Inhibition of the mtorc pathway in the antiphospholipid
Marcus, Author at DiaPharma
Nonstandard and adjunctive medical therapies for systemic lupus erythematosus - McMurray - 2001 - Arthritis Care & Research - Wiley Online Library
T sejtek és kemokinek változásának vizsgálata SLE pulmonalis manifesztációjában Doktori értekezés Dr.Vincze Krisztina
Logistic regression predicting those with >80% time in therapeutic range | Download Table
Diagnosis and treatment of lupus nephritis. Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Nephrology (S.E.N.) | Nefrología
Savino Sciascia (@SavinoSciascia) / Twitter
Nőgyógyászati kórképek genetikai háttere - A thrombosis kapcsolata a vetéléssel - MeRSZ
Frontiers | Thrombosis and Inflammation—A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C
Inhibition of the mtorc pathway in the antiphospholipid
Neutrophil Extracellular Traps May Augur Severe COVID-19 | The Scientist Magazine®
Frontiers | Thrombin generation assays to personalize treatment in bleeding and thrombotic diseases
COVID-19 Breaking News! French Study Confirms Previous Coronavirus Immunity Offers No Protection Against SARS-CoV-2 - Thailand Medical News
Treatment of lupus nephritis: consensus, evidence and perspectives | Nature Reviews Rheumatology
Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid
Savino Sciascia (@SavinoSciascia) / Twitter
Evaluation of the Degree of Confidence. | Download Scientific Diagram
Frontiers | Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine
PDF) Immunogenicity and safety after SARS-CoV-2 vaccine in Primary Antiphospholipid Syndrome (PAPS)
Inhibition of the mtorc pathway in the antiphospholipid
